Skip to main content

Proceeding contribution from Lord Lansley (Conservative) in the House of Commons on Thursday, 8 December 2005. It occurred during Estimates day on Department of Health.


Department of Health

This is an interesting point, and I hope that the Minister will tell us more about electronic prescribing and about the conversion of the Prescription Pricing Authority on to an electronic basis. That should, in theory, allow us to extract much more of the data that the right hon. Gentleman describes. However, although the transfer to electronic prescribing has increased, we are still achieving only a tiny fraction of the amount that was intended. By this stage, we were expecting to have pretty much an entirely electronic system, from the doctor’s screen right through to reimbursement through the PPA.


Secondary information

Type
Proceeding contribution
Reference
440 c1024 
Session
2005-06
Chamber / Committee
House of Commons chamber
Subjects
Advertising Licensing Expenditure Drugs Government departments Industry Prescription drugs Department of Health Medicines and Healthcare products Regulatory Agency Research Regulation Safety National Institute for Health and Care Excellence Registration Clinical trials
Link
View this Proceeding contribution on www.publications.parliament.uk